Tyra Biosciences Inc (NASDAQ: TYRA) on Friday, plunged -23.35% from the previous trading day, before settling in for the closing price of $28.61. Within the past 52 weeks, TYRA’s price has moved between $10.38 and $29.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 5.56%. With a float of $28.82 million, this company’s outstanding shares have now reached $43.02 million.
In an organization with 49 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 13.94%, operating margin of -19014.14%, and the pretax margin is -16110.76%.
Tyra Biosciences Inc (TYRA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tyra Biosciences Inc is 45.34%, while institutional ownership is 49.64%. The most recent insider transaction that took place on Oct 18 ’24, was worth 1,178,796. In this transaction President and CEO of this company sold 43,636 shares at a rate of $27.01, taking the stock ownership to the 1,375,011 shares. Before that another transaction happened on Oct 21 ’24, when Company’s President and CEO sold 19,084 for $27.90, making the entire transaction worth $532,451. This insider now owns 1,355,927 shares in total.
Tyra Biosciences Inc (TYRA) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.49 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.35) by -0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.56% per share during the next fiscal year.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Tyra Biosciences Inc (TYRA) is currently performing well based on its current performance indicators. A quick ratio of 36.46 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.69, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.90 in one year’s time.
Technical Analysis of Tyra Biosciences Inc (TYRA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.76 million. That was better than the volume of 0.17 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.22%. Additionally, its Average True Range was 2.05.
During the past 100 days, Tyra Biosciences Inc’s (TYRA) raw stochastic average was set at 46.55%, which indicates a significant increase from 23.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 129.33% in the past 14 days, which was higher than the 73.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.87, while its 200-day Moving Average is $18.99. However, in the short run, Tyra Biosciences Inc’s stock first resistance to watch stands at $24.19. Second resistance stands at $26.45. The third major resistance level sits at $28.74. If the price goes on to break the first support level at $19.64, it is likely to go to the next support level at $17.35. The third support level lies at $15.09 if the price breaches the second support level.
Tyra Biosciences Inc (NASDAQ: TYRA) Key Stats
Market capitalization of the company is 1.16 billion based on 52,540K outstanding shares. Right now, sales total 0 K and income totals -69,130 K. The company made 0 K in profit during its latest quarter, and -18,700 K in sales during its previous quarter.
